NAMS
Price
$27.00
Change
+$1.34 (+5.22%)
Updated
Sep 5 closing price
Capitalization
3.04B
72 days until earnings call
WXXWY
Price
$9.35
Change
+$0.19 (+2.07%)
Updated
Sep 5 closing price
Capitalization
19.16B
88 days until earnings call
Interact to see
Advertisement

NAMS vs WXXWY

Header iconNAMS vs WXXWY Comparison
Open Charts NAMS vs WXXWYBanner chart's image
NewAmsterdam Pharma
Price$27.00
Change+$1.34 (+5.22%)
Volume$1.57M
Capitalization3.04B
Wuxi Biologics (Cayman)
Price$9.35
Change+$0.19 (+2.07%)
Volume$23.33K
Capitalization19.16B
NAMS vs WXXWY Comparison Chart in %
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. WXXWY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Buy and WXXWY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (NAMS: $27.00 vs. WXXWY: $9.35)
Brand notoriety: NAMS and WXXWY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 185% vs. WXXWY: 65%
Market capitalization -- NAMS: $3.04B vs. WXXWY: $19.16B
NAMS [@Biotechnology] is valued at $3.04B. WXXWY’s [@Biotechnology] market capitalization is $19.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileWXXWY’s FA Score has 1 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • WXXWY’s FA Score: 1 green, 4 red.
According to our system of comparison, both NAMS and WXXWY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 5 TA indicator(s) are bullish while WXXWY’s TA Score has 4 bullish TA indicator(s).

  • NAMS’s TA Score: 5 bullish, 4 bearish.
  • WXXWY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than WXXWY.

Price Growth

NAMS (@Biotechnology) experienced а +12.27% price change this week, while WXXWY (@Biotechnology) price change was +10.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

NAMS is expected to report earnings on Nov 17, 2025.

WXXWY is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXXWY($19.2B) has a higher market cap than NAMS($3.04B). WXXWY YTD gains are higher at: 111.180 vs. NAMS (5.058).
NAMSWXXWYNAMS / WXXWY
Capitalization3.04B19.2B16%
EBITDA-237.93MN/A-
Gain YTD5.058111.1805%
P/E RatioN/A34.07-
Revenue64MN/A-
Total Cash739MN/A-
Total Debt328KN/A-
FUNDAMENTALS RATINGS
WXXWY: Fundamental Ratings
WXXWY
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSWXXWY
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
40%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
70%
Bearish Trend 10 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEDRX35.21N/A
N/A
Invesco International Value R
NBGUX31.69N/A
N/A
Neuberger Berman Large Cap Growth Adv
STMOX35.16N/A
N/A
Sterling Capital Real Estate C
RGLHX26.99N/A
N/A
American Funds Global Insight R-2E
MVGNX18.52N/A
N/A
MFS Low Volatility Global Equity R6

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with QURE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+5.22%
QURE - NAMS
57%
Loosely correlated
+1.24%
CRDF - NAMS
42%
Loosely correlated
+1.88%
IRON - NAMS
39%
Loosely correlated
+0.95%
BEAM - NAMS
38%
Loosely correlated
+12.62%
OCUL - NAMS
37%
Loosely correlated
+7.09%
More

WXXWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXXWY has been loosely correlated with WXIBF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXXWY jumps, then WXIBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXXWY
1D Price
Change %
WXXWY100%
+2.07%
WXIBF - WXXWY
46%
Loosely correlated
N/A
ONC - WXXWY
36%
Loosely correlated
+7.24%
SNBIF - WXXWY
28%
Poorly correlated
N/A
NAMS - WXXWY
23%
Poorly correlated
+5.22%
ZLAB - WXXWY
23%
Poorly correlated
+2.53%
More